Tie-2 is overexpressed by monocytes in autoimmune thyroid disorders and participates in their recruitment to the thyroid gland

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2626-2633

  Figueroa Vega, Nicté ^a,b   Alfonso Pérez, Manuel ^b   Cuesta Mateos, Carlos ^b   Sánchez Madrid, Francisco ^b   Moreno Otero, Ricardo ^b   González Amaro, Roberto ^a   Marazuela, Mónica ^b  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ANTITHYROID AGENT; CARBIMAZOLE; IODINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MONOCYTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID GLAND; TISSUE INJURY;

EID: 67650236588     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0220     Document Type: Article

References (44)

1. Weetman AP 2004 Autoimmune thyroid disease. Autoimmunity 37:337-340
2. Bidey SP, Hill DJ, Eggo MC 1999 Growth factors and goitrogenesis. J Endocrinol 160:321-332
3. Marazuela M 1999 Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur J Endocrinol 140:287-290
4. Postigo AA, Marazuela M, Sánchez-Madrid F, de Landázuri MO 1994 B Lymphocyte binding to E- and P-selectins is mediated through the de novo expression of carbohydrates on in vitro and in vivo activated human B cells. J Clin Invest 94:1585-1596
5. González-Amaro R, Díaz-González F, Sánchez-Madrid F 1998 Adhesion molecules in inflammatory diseases. Drugs 56:977-988
6. Weetman AP 2004 Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol (Oxf) 61:405-413
7. García-López MA, Sancho D, Sánchez-Madrid F, Marazuela M 2001 Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86:5008-5016
8. Carmeliet P 2003 Angiogenesis in health and disease. Nat Med 9:653-660
9. Ramsden JD 2000 Angiogenesis in the thyroid gland. J Endocrinol 166:475-480
10. Salcedo X, Medina J, Sanz-Cameno P, García-Buey L, Martín-Vilchez S, Borque MJ, López-Cabrera M, Moreno-Otero R 2005 The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 42:696-701
11. Bunone G, Vigneri P, Mariani L, ButóS, Collini P, Pilotti S, Pierotti MA, Bongarzone I 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155:1967-1976
12. Eklund L, Olsen BR 2006 Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312:630-641
13. Fiedler U, Augustin HG 2006 Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 27:552-558
14. Jones PF 2003 Not just angiogenesis - wider roles for the angiopoietins. J Pathol 201:515-527
15. Ramsden JD, Cocks HC, Shams M, Nijjar S, Watkinson JC, Sheppard MC, Ahmed A, Eggo MC 2001 Tie-2 is expressed on thyroid follicular cells, is increased in goiter, and is regulated by thyrotropin through cyclic adenosine 3′,5′-monophosphate. J Clin Endocrinol Metab 86:2709-2716
16. Carmeliet P 2005 Angiogenesis in life, disease and medicine. Nature 438:932-936
17. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
18. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG 2005 The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 118:771-780
19. Lobov IB, Brooks PC, Lang RA 2002 Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99:11205-11210
20. Martin V, Liu D, Fueyo J, Gomez-Manzano C 2008 Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol 23:773-780
21. Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, Zonari E, Mazzieri R, Doglioni C, Naldini L 2007 Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109:5276-5285
22. Murdoch C, Tazzyman S, Webster S, Lewis CE 2007 Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178:7405-7411
23. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE 2007 Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 28:519-524
24. Uchida T, Nakashima M, Hirota Y, Miyazaki Y, Tsukazaki T, Shindo H 2000 Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis 59:607-614
25. Plank MJ, Sleeman BD, Jones PF 2004 The role of the angiopoietins in tumour angiogenesis. Growth Factors 22:1-11
26. Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M 2001 Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol 116:713-720
27. Mitsutake N, Namba H, Takahara K, Ishigaki K, Ishigaki J, Ayabe H, Yamashita S 2002 Tie-2 and angiopoietin-1 expression in human thyroid tumors. Thyroid 12:95-99
28. NiedŸwiecki S, Stepieñ T, Kopeæ K, Kuzdak K, Komorowski J, Krupiñski R, Stepieñ H 2006 Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers. Cytokine 36:291-295
29. Shahrara S, Volin MV, Connors MA, Haines GK, Koch AE 2002 Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 4:201-208
30. Figueroa-Vega N, Sanz-Cameno P, Moreno-Otero R, Sanchez-Madrid F, Gonzalez-Amaro R, Marazuela M 2009 Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features. J Clin Endocrinol Metab 94:1145-1153
31. Nilsson M, Husmark J, Nilsson B, Tisell LE, Ericson LE 1996 Primary culture of human thyrocytes in Transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Eur J Endocrinol 135:469-480
32. Acevedo A, del Pozo MA, Arroyo AG, Sánchez-Mateos P, González-Amaro R, Sánchez-Madrid F 1993 Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells. Am J Pathol 143:774-783
33. DeBusk LM, Chen Y, Nishishita T, Chen J, Thomas JW, Lin PC 2003 Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 48:2461-2471
34. Sanz-Cameno P, Martín-Vílchez S, Lara-Pezzi E, Borque MJ, Salmerón J, Muñoz de Rueda P, Solís JA, López-Cabrera M, Moreno-Otero R 2006 Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein. Am J Pathol 169:1215-1222
35. Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ 2006 Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol 54:1003-1012
36. Karlsson FA, Tötterman TH 1988 Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells. Clin Exp Immunol 74:258-263
37. Kim H, Lee TH, Hwang YS, Bang MA, Kim KH, Suh JM, Chung HK, Yu DY, Lee KK, Kwon OY, Ro HK, Shong M 2001 Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-γ signaling and H(2)O(2) scavenging. Mol Pharmacol 60:972-980
38. Yamakawa M, Liu LX, Belanger AJ, Date T, Kuriyama T, Goldberg MA, Cheng SH, Gregory RJ, Jiang C 2004 Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis. Am J Physiol Renal Physiol 287:F649-F657
39. Donckier JE, Michel L, Delos M, Havaux X, Van Beneden R 2006 Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma. Clin Endocrinol (Oxf) 64:703-710
40. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M 1995 Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest 96:1295-1302
41. Klein M, Catargi B 2007 VEGF in physiological process and thyroid disease. Ann Endocrinol (Paris) 68:438-448
42. Imhof BA, Aurrand-Lions M 2006 Angiogenesis and inflammation face off. Nat Med 12:171-172
43. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF 1995 Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone nonobese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 147:311-320
44. Nolan VG, Adewoye A, Baldwin C, Wang L, Ma Q, Wyszynski DF, Farrell JJ, Sebastiani P, Farrer LA, Steinberg MH 2006 Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-β/BMP pathway. Br J Haematol 133:570-578